ATE359784T1 - Topische nasenbehandlung mit desloratadin und mometason furoat - Google Patents

Topische nasenbehandlung mit desloratadin und mometason furoat

Info

Publication number
ATE359784T1
ATE359784T1 AT00968725T AT00968725T ATE359784T1 AT E359784 T1 ATE359784 T1 AT E359784T1 AT 00968725 T AT00968725 T AT 00968725T AT 00968725 T AT00968725 T AT 00968725T AT E359784 T1 ATE359784 T1 AT E359784T1
Authority
AT
Austria
Prior art keywords
desloratadine
topical
mometasone furoate
nose treatment
nose
Prior art date
Application number
AT00968725T
Other languages
German (de)
English (en)
Inventor
Stephen J Andrzejewski
William Kreutner
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE359784T1 publication Critical patent/ATE359784T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00968725T 1999-10-08 2000-10-05 Topische nasenbehandlung mit desloratadin und mometason furoat ATE359784T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41508399A 1999-10-08 1999-10-08

Publications (1)

Publication Number Publication Date
ATE359784T1 true ATE359784T1 (de) 2007-05-15

Family

ID=23644317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968725T ATE359784T1 (de) 1999-10-08 2000-10-05 Topische nasenbehandlung mit desloratadin und mometason furoat

Country Status (9)

Country Link
EP (1) EP1227812B1 (enExample)
JP (3) JP2003511417A (enExample)
AR (1) AR025964A1 (enExample)
AT (1) ATE359784T1 (enExample)
AU (1) AU7859800A (enExample)
CA (1) CA2383970A1 (enExample)
DE (1) DE60034476T2 (enExample)
ES (1) ES2284531T3 (enExample)
WO (1) WO2001026658A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101434A2 (en) * 2001-12-21 2003-12-11 Sampad Bhattacharya Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor
TR200201343A2 (tr) * 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
MXPA05005044A (es) * 2002-11-12 2005-07-01 Alcon Inc El uso de un agente antialergico y un esteroide para tratar rinitis alergica.
EP3103422A1 (en) 2003-03-14 2016-12-14 Intersect ENT, Inc. Sinus delivery of sustained release therapeutics
WO2004082589A2 (en) * 2003-03-20 2004-09-30 Ranbaxy Laboratories Limited Nasally administrable, bioavailable pharmaceutical composition of loratadine
US20050192261A1 (en) * 2003-09-15 2005-09-01 Jost-Price Edward R. Methods and reagents for the treatment of immunoinflammatory disorders
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
CA2603081C (en) 2005-04-04 2013-09-03 Sinexus, Inc. Device and methods for treating paranasal sinus conditions
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
CA2657581A1 (en) * 2006-07-11 2008-01-17 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
AU2007311607A1 (en) * 2006-10-19 2008-04-24 Cipla Limited Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate
EP2231065B8 (en) 2007-12-18 2021-01-06 Intersect ENT, Inc. Self-expanding devices
CA2732355A1 (en) 2008-08-01 2010-02-04 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
KR101099826B1 (ko) 2009-02-16 2011-12-27 서울대학교산학협력단 항알러지성 약물을 활성성분으로 함유하는 비강투여용 액상제제
EP2754463B1 (en) 2009-05-15 2016-06-22 Intersect ENT, Inc. Expandable devices
WO2011141929A2 (en) 2010-05-11 2011-11-17 Cadila Healthcare Limited Aqueous pharmaceutical compositions of fluticasone and olopatadine
FR2970180B1 (fr) * 2011-01-06 2013-08-02 Substipharm Dev Procede de preparation de suspensions aqueuses pharmaceutiques comprenant un medicament efficace dans le traitement des rhinites
US9362391B2 (en) 2011-09-21 2016-06-07 Mitsubishi Electric Corporation Silicon carbide semiconductor device and method of manufacturing the same
EP3636227B1 (en) 2013-03-14 2024-08-28 Intersect ENT, Inc. Systems and devices for treating a sinus condition
US9370483B2 (en) 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
JP6203967B2 (ja) 2013-09-13 2017-09-27 グレンマーク・スペシャルティー・エスエー モメタゾン及びオロパタジンを有する安定な定用量薬剤組成物
US9937189B2 (en) 2013-09-13 2018-04-10 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
RU2686670C2 (ru) 2013-10-04 2019-04-30 Гленмарк Спешиалити С.А. Лечение аллергического ринита с использованием комбинации мометазона и олопатадина
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
US20160120928A1 (en) * 2014-11-03 2016-05-05 Zent, Inc. Nasal spray
WO2017023162A1 (en) * 2015-08-04 2017-02-09 Inqpharm Group Sdn Bhd A nasal composition
CN106619504A (zh) * 2016-11-10 2017-05-10 北京万全德众医药生物技术有限公司 一种地氯雷他定口服滴剂及其制备方法
CA3088490A1 (en) * 2018-02-23 2019-08-29 Glenmark Specialty S.A. Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine
US12303635B2 (en) 2018-04-16 2025-05-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
WO2019245015A1 (ja) * 2018-06-22 2019-12-26 参天製薬株式会社 デスロラタジン又はその塩を含有する医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK140493A3 (en) * 1991-06-10 1994-10-05 Schering Corp Non-chlorofluorocarbon aerosol formulations
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
WO2000051605A1 (en) * 1999-03-01 2000-09-08 Schering Corporation Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids

Also Published As

Publication number Publication date
WO2001026658A3 (en) 2002-02-21
EP1227812A2 (en) 2002-08-07
JP2008056698A (ja) 2008-03-13
ES2284531T3 (es) 2007-11-16
AU7859800A (en) 2001-04-23
DE60034476D1 (de) 2007-05-31
JP2007106777A (ja) 2007-04-26
EP1227812B1 (en) 2007-04-18
CA2383970A1 (en) 2001-04-19
AR025964A1 (es) 2002-12-26
JP2003511417A (ja) 2003-03-25
DE60034476T2 (de) 2008-01-03
WO2001026658A2 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
ATE359784T1 (de) Topische nasenbehandlung mit desloratadin und mometason furoat
DE69924155D1 (de) Fluoren-copolymere und daraus hergestellte vorrichtungen
DE60001107D1 (de) Sichere und handliche hinweisanordung
FI20115742L (fi) Mometasonifuroaatin käyttö lääkkeen valmistuksessa
EP1419245A4 (en) ADENO-ASSOCIATED PSEUDOTYPE VIRUSES AND USES THEREOF
DE50000979D1 (de) Lenkvorrichtung und lenkverfahren
DE60019490D1 (de) Brennstofförder-und behandlungsvorrichtung
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
AU2003265225A8 (en) Preparations for topical skin use and treatment
EP1514529A4 (en) CATHETER FOR TOPICAL COOLING AND TOPICAL COOLING DEVICE USING THE CATHETER
DE602004027120D1 (de) Orale und/oder topische Zubereitungen
DE60135287D1 (de) Saugfähiger Einwegartikel und Schutzmittel
EE200200214A (et) Dipüridamooli või mopidamooli kasutamine sellise ravimi valmistamiseks, mis on ette nähtud fibriinsõltuvate mikrotsirkulatsiooni häirete ennetamiseksja raviks
ATE285942T1 (de) Foliebehandlungsvorrichtung und umwickelvorrichtung
DE60304229D1 (de) Pinselabflacher und mit Pinselabflacher ausgerüstete Zeichenvorrichtung
DE69832364D1 (de) Therapiegerät und entsprechendes Herstellungsverfahren
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DE50005409D1 (de) Hör-behandlungsgerät
DE60023003D1 (de) Haarbehandlungsmittel
DE69932577D1 (de) Stangenbehandlungsgerät und Stangenladegerät
DE60216899D1 (de) Hormonsubstitutionstherapie und seine darreichungsformen
DE50206175D1 (de) Thiochromenone gegen schmerzzustände und neurodegenerative erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties